Satya Nadella and Michel Vounatsos are linked by one documented event. On 5 November 2021, both signed an open letter from the International Leadership Group for a Net Zero NHS, published by The BMJ, urging the NHS supply chain to cut carbon emissions by 2045 at the latest. Nadella signed as Microsoft CEO and Vounatsos as Biogen CEO. No shared employer, business partnership or family tie has been verified.
If you reach this page after seeing their names side by side in search results, this guide separates what public records confirm from what content sites keep repeating. Every date and role below comes from primary sources such as the BMJ press release, Microsoft and Biogen announcements, SEC filings and company board pages, and was checked in October 2026.
Quick Answer: How Are Satya Nadella and Michel Vounatsos Connected?
They are connected through a single public letter. On 5 November 2021 The BMJ published an open letter from the International Leadership Group for a Net Zero NHS, and both men appear in its list of signatories. Nadella represented Microsoft and Vounatsos represented Biogen. Beyond that letter, no direct business or personal link is documented.
Key facts at a glance:
- Date of the letter: 5 November 2021
- Where it appeared: The BMJ, as a rapid response and a press release
- Their titles in 2021: Nadella was CEO of Microsoft, Vounatsos was CEO of Biogen
- Their roles in 2026: Nadella is Chairman and CEO of Microsoft, while Vounatsos sits on company boards and has not been Biogen CEO since November 2022
- Not confirmed: a partnership, a shared employer or a family relationship
Satya Nadella vs Michel Vounatsos at a Glance
| Detail | Satya Nadella | Michel Vounatsos |
| Current role | Chairman and CEO of Microsoft | Independent director at Zai Lab, director at Revvity |
| Role in 2021 | CEO of Microsoft | CEO of Biogen |
| Industry | Software, cloud computing | Biopharma, neuroscience |
| CEO since | February 2014 | 6 January 2017 |
| Stepped down as CEO | Still CEO | November 2022 |
| Earlier employers | Sun Microsystems | Ciba Geigy, Merck |
| Education | Manipal Institute of Technology, University of Wisconsin in Milwaukee, University of Chicago Booth | HEC Paris MBA, medical certificate from Bordeaux II |
| Link between them | Signed the 2021 BMJ letter | Signed the 2021 BMJ letter |
The 2021 Net Zero NHS Open Letter Explained
What the BMJ Letter Said
The International Leadership Group for a Net Zero NHS was led by Lord Prior, who was then chairman of NHS England. It brought together chief executives of major NHS suppliers, trade bodies, The BMJ, the Health Foundation and the food system group EAT. On 5 November 2021 the group wrote to the 80,000 global suppliers in the NHS supply chain and asked them to commit to decarbonise their operations by 2045 at the latest.
The reasoning was simple. The NHS had already committed to reach net zero carbon by 2040 for the emissions it controls, yet nearly two thirds of its carbon footprint sits in its global supply chain. Hospitals cannot fix that alone. NHS England’s own June 2021 progress paper confirms the group was formed to build support for the NHS net zero goals ahead of the COP26 climate summit, with Lord Prior in the chair.
The letter was published as a rapid response on bmj.com under the title “A commitment to decarbonise by 2045”. It also carries a DOI, 10.1136/bmj.n2425, which makes it easy to cite.
Read Also: Travis Kalanick and Helen Mirren: Are They Connected? (2026)
Who Else Signed the Letter
The press release lists eighteen names in three groups. The twelve supplier signatories were:
- Alan Jope, CEO of Unilever
- Alex Gorsky, Chairman and CEO of Johnson & Johnson
- Dame Emma Walmsley, CEO of GSK
- Geoff Martha, Chairman and CEO of Medtronic
- Lars Fruergaard Jørgensen, President and CEO of Novo Nordisk
- Lisa Jackson, Vice President for Environment, Policy and Social Initiatives at Apple
- Michel Vounatsos, CEO of Biogen
- Pascal Soriot, CEO of AstraZeneca
- Philip Jansen, CEO of BT Group
- Roland Diggelmann, CEO of Smith+Nephew
- Satya Nadella, CEO of Microsoft
- Xavier Martiré, Chairman of the Management Board and CEO of Elis
Three trade bodies also signed: the Biotechnology Innovation Organization, the Association of British HealthTech Industries and the Association of the British Pharmaceutical Industry. The three independent members were Dr Fiona Godlee of The BMJ, Dr Gunhild Stordalen of EAT and Dr Jennifer Dixon of the Health Foundation.
One detail most articles miss: Apple signed through a senior environment executive rather than its CEO, so calling it a “CEO letter” is slightly loose. Nadella and Vounatsos, however, both signed personally as chief executives.
Why Microsoft and Biogen Were Part of the Group
The BMJ release does not explain why each company was chosen. The group simply gathered large suppliers across technology, pharmaceuticals and medical devices. For Microsoft, the fit is easy to see.
On 16 January 2020 Nadella announced, alongside Brad Smith, Amy Hood and Lucas Joppa, that Microsoft would be carbon negative by 2030 and would remove by 2050 all the carbon it had emitted since its founding in 1975. The plan included a one billion dollar climate innovation fund and a promise to make carbon reduction part of its supplier procurement process.
Biogen sat in the pharmaceutical segment of the same supply chain. Its CEO signing alongside Microsoft’s shows how the NHS wanted suppliers from very different industries to sign the same commitment.
What the NHS Targets Actually Are
NHS England set two dates. Net zero by 2040 for the emissions it controls directly, and net zero by 2045 for the emissions it can influence, mainly through suppliers. Five days after the BMJ letter, on 10 November 2021, Health Secretary Sajid Javid wrote to NHS trust chiefs that from 2030 the NHS would stop buying from suppliers that are not aligned with its net zero ambitions. That is why a supplier letter signed by the heads of Microsoft and Biogen carried real commercial weight.
Career and Connection Timeline
| Date | Event |
| 1990 to 1996 | Vounatsos holds management roles at Ciba Geigy |
| 1992 | Nadella joins Microsoft after working at Sun Microsystems |
| 1996 to 2016 | Vounatsos works at Merck, including President of MSD China from 2008 to 2012 and later President of Primary Care |
| February 2014 | Nadella becomes the third CEO of Microsoft |
| April 2016 | Vounatsos joins Biogen as Chief Commercial Officer |
| 6 January 2017 | Vounatsos becomes Biogen CEO |
| 16 January 2020 | Microsoft pledges to be carbon negative by 2030 |
| 1 March 2020 | Vounatsos joins the board of PerkinElmer, now Revvity |
| 16 June 2021 | Microsoft names Nadella chairman |
| 5 November 2021 | Both sign the BMJ Net Zero NHS open letter |
| May 2022 | Biogen announces Vounatsos will step down |
| 10 November 2022 | Biogen names Christopher Viehbacher CEO, effective 14 November |
| 7 January 2023 | Vounatsos joins the Zai Lab board |
| Early 2024 | Vounatsos is named to the AIVITA Biomedical board |
| 2026 | Nadella remains Chairman and CEO, Vounatsos is still listed on the Zai Lab board |
Who Is Satya Nadella?
Early Life and Education
Satya Nadella was born on 19 August 1967 in Hyderabad, India. He attended Hyderabad Public School in Begumpet and earned a bachelor’s degree in electrical engineering in 1988 from the Manipal Institute of Technology. That institute was then affiliated with Mangalore University, which explains why some official bios name Mangalore University and others name Manipal.
Both describe the same degree. He then moved to the United States, completed a master’s in computer science at the University of Wisconsin in Milwaukee in 1990 and later earned an MBA from the University of Chicago Booth School of Business.
Career at Microsoft
Nadella worked at Sun Microsystems before joining Microsoft in 1992. Over the years he led research and development for Online Services, served as a vice president in the Business Division and then became Executive Vice President of the Cloud and Enterprise group, where he drove the shift toward Azure and cloud infrastructure.
In February 2014 he succeeded Steve Ballmer as CEO, only the third in Microsoft’s history after Bill Gates and Ballmer. Acquisitions during his tenure include LinkedIn, GitHub, ZeniMax and Nuance Communications.
Current Role and Why He Was Relevant to the NHS Initiative
On 16 June 2021 Microsoft’s independent directors unanimously elected Nadella chairman, replacing John Thompson, who became lead independent director. Microsoft’s own executive page still lists him as Chairman and Chief Executive Officer.
His relevance to the NHS group comes from Microsoft’s role as a technology supplier and from the carbon negative pledge he announced in 2020. On the personal side, he is married to Anupama Nadella, they have three children, and he keeps family life largely private.
Also Read This: Millie Bobby Brown and Safra Catz: Real Link or Myth? (2026)
Who Is Michel Vounatsos?
Background and Education
Michel Vounatsos began in pharmaceuticals at Ciba Geigy, where he held management positions from 1990 to 1996. He then spent twenty years at Merck, working across Europe, China and the United States.
He served as President of MSD China from 2008 to 2012 and later as President of Primary Care and Merck Customer Centricity. He holds an MBA from HEC Paris and a certificate in clinical and therapeutic synthesis in medicine from Université Victor Segalen, Bordeaux II.
Michel Vounatsos at Biogen
Vounatsos joined Biogen in April 2016 as Executive Vice President and Chief Commercial Officer. Biogen appointed him CEO effective 6 January 2017, succeeding George Scangos, and its board said it wanted a leader with a strong record in building commercial operations. During his tenure Biogen positioned itself as a leader in neuroscience.
His departure was announced in May 2022. Reports at the time linked it to disappointing results and weakened prospects for the Alzheimer’s drug Aduhelm, and Biogen announced a 500 million dollar cost reduction program in the same month.
On 10 November 2022 Biogen named Christopher Viehbacher, the former Sanofi CEO, as President and CEO effective 14 November. Vounatsos stayed employed for a limited period to help with the transition. So the answer to “Is Michel Vounatsos still Biogen CEO?” is no.
What Does Michel Vounatsos Do Now?
He now works mainly as a board director:
- Zai Lab: independent director since 7 January 2023. He chairs the Commercial Committee and sits on the Research and Development Committee. Zai Lab’s May 2026 announcement still lists him as a director.
- Revvity: on the board since 1 March 2020, when the company was still PerkinElmer. Company bios say he has chaired its Nominating and Corporate Governance Committee since October 2022.
- AIVITA Biomedical: named to the board in early 2024, as listed in the February 2024 board moves report and on the company’s own leadership page.
- Academic and institute roles: he sits on the advisory board of the Tsinghua University School of Pharmaceutical Sciences in Beijing and chairs the supervisory board of Liryc, the heart rhythm institute at the University of Bordeaux.
Board seats change at annual meetings, so check each company’s investor page before you quote a current position.
Did Satya Nadella and Michel Vounatsos Work Together, Partner or Share a Family Link?
Did They Work for the Same Company?
No. Nadella has been a Microsoft executive since 1992. Vounatsos moved from Ciba Geigy to Merck to Biogen. Neither company’s records show the other man as an employee.
Were They Business Partners?
No joint company, investment or project involving both men appears in the BMJ release, SEC filings or company announcements reviewed. Signing the same letter is a shared public commitment, not a contract.
Are They Related?
No source supports a family relationship. Their backgrounds are also very different: Nadella grew up in Hyderabad and built his career in technology, while Vounatsos built his in European and American pharmaceutical companies.
Why Their Names Appear Together in Search
Search engines connect two names when both appear in the same document. The BMJ signatory list is exactly that kind of document. Many content sites then stretch a shared signature into a “relationship” to fill pages, which is why you will find claims of friendship or partnership with no evidence behind them.
A quick way to test any claim like this yourself: find the organisation’s own press release, read the full list of names, check dates against official announcements, and look for the same pairing in SEC filings or board pages. If none of those show a direct link, treat the claim as unproven.
Technology vs Pharma Leadership Compared
Microsoft Under Nadella
Nadella’s tenure is tied to cloud computing, Azure, large acquisitions such as LinkedIn and GitHub, and corporate climate targets like the 2030 carbon negative goal. His role expanded from CEO to chairman in 2021.
Biogen Under Vounatsos
Vounatsos led a neuroscience focused biotech company from 2017 to 2022. His tenure included the high profile Aduhelm episode, followed by a cost reduction program and a change of CEO. Since then his work has shifted to boards in biopharma and life science tools.
Where Their Paths Overlap
Their industries differ, but both were chief executives of major NHS suppliers in 2021, and both put their names to the same decarbonisation commitment. That overlap is real, narrow and well documented, and it is the only one the evidence supports.
Also Read This: Wayne Gretzky And Larry Culp: Are They Connected? Facts 2026
Confirmed vs Not Confirmed: What the Evidence Supports
| Claim | Status | Evidence |
| Both signed the 2021 BMJ Net Zero NHS letter | Confirmed | BMJ press release, 5 November 2021 |
| Nadella is Chairman and CEO of Microsoft | Confirmed | Microsoft executive profile, June 2021 board announcement |
| Vounatsos was Biogen CEO from 2017 to 2022 | Confirmed | Biogen releases |
| Vounatsos is the current Biogen CEO | False | Viehbacher CEO since 14 November 2022 |
| Vounatsos is a Zai Lab director | Confirmed as of May 2026 | Zai Lab announcement |
| They worked at the same company | No evidence | Employment histories differ |
| They are business partners | No evidence | No joint filing or announcement |
| They are related | No evidence | No source found |
| A specific net worth for either man | Not verified | Only estimates exist |
FAQ’s
Why are Satya Nadella and Michel Vounatsos mentioned together?
Both signed the 5 November 2021 BMJ open letter from the International Leadership Group for a Net Zero NHS. Nadella signed as Microsoft CEO and Vounatsos as Biogen CEO.
What was the Net Zero NHS open letter?
It was a message to the 80,000 suppliers in the NHS supply chain asking them to commit to decarbonise their operations by 2045 at the latest, supporting the NHS goal of becoming the first net zero health service.
Did they work for the same company?
No. Nadella is a long time Microsoft executive, while Vounatsos worked at Ciba Geigy, Merck and Biogen.
Are they business partners or related?
No source shows a partnership or a family relationship. Their only documented link is the shared letter.
Is Michel Vounatsos still Biogen’s CEO?
No. Christopher Viehbacher took over on 14 November 2022.
What does Michel Vounatsos do now?
He serves on the boards of Zai Lab and Revvity and was named to AIVITA Biomedical’s board in early 2024. He also holds academic and institute roles in China and France.
Is Satya Nadella still Microsoft’s CEO and chairman?
Yes. He has been CEO since February 2014 and chairman since June 2021, according to Microsoft’s own executive profile.
Who succeeded Michel Vounatsos at Biogen?
Christopher Viehbacher, the former CEO of Sanofi, succeeded him effective 14 November 2022.
What is their net worth?
No verified figure exists for either man. Filings show pay and share holdings, not total wealth, so any single number online is an estimate.
What did the NHS ask suppliers to do by 2045?
To decarbonise their operations by 2045 at the latest, in line with the NHS target of net zero for emissions it influences.
Conclusion
Satya Nadella and Michel Vounatsos come from different worlds, yet their names meet in one verified place: the 5 November 2021 BMJ open letter urging NHS suppliers to decarbonise by 2045.
Nadella remains Chairman and CEO of Microsoft, while Vounatsos has moved from running Biogen to serving on boards such as Zai Lab and Revvity. The honest summary is a shared commitment, not a partnership, and that distinction is what separates a reliable answer from a recycled one.
